VIDEO: Are vaccines the solution for high pathogenic avian influenza?

30-03-2023 | Updated on 28-05 |Partner | Health

High Pathogenic Avian Influenza H5 (HPAI H5) has become a growing concern for the poultry industry, with the virus spreading to new regions and causing significant economic losses. But what is the next step?

In this video, Corporate Marketing Manager of Poultry Mustafa Seçkin Sandikli from Ceva will talk about HPAI H5. Is it endemic? What is new? Why is it a threat? And most importantly, what is next?

Join 31,000+ subscribers

Subscribe to our newsletter to stay updated about all the need-to-know content in the poultry sector, three times a week.

"*" indicates required fields

More about

Ceva Santé Animale Company profile

Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines, pharmaceutical and animal welfare products for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With 6,500 employees located in 47 countries, Ceva strives daily to bring to life its vision as a OneHealth company: “Together, beyond animal health”. 2022 turnover: €1.53 billion. Use the links below to learn more about Ceva.